Phthalocyanine-based probes in alleviating or evading tumour-hypoxia for enhanced photo- and/ sono-mediated therapeutic efficacies
Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved..
This review discusses the possible methods for improving therapeutic efficacies of phthalocyanine (Pcs) -based therapeutic probes in photo- and sono-dynamic therapies under hypoxic conditions. Herein, the structural design strategies including varying the central metal, position substituents and the effects of adjuvant used in supplementing the therapeutics activities of Pcs or formation of NPs are discussed for cancer therapies in hypoxic conditions. Different mechanisms induced for cell death influenced by the compositions of the Pcs-probes are discussed. The focus mainly highlights the oxygen (O2) -dependent mechanisms including methods of supplementing tumour microenvironment O2-concentrations to promote PDT or SDT therapies. Alternatively, O2-independent mechanisms mainly used to evade hypoxia by stimulating anticancer processes that don't require O2 to initiate cell death, such as the Fenton reaction or thermal ablation effects.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
---|---|
Enthalten in: |
Photodiagnosis and photodynamic therapy - 46(2024) vom: 22. Feb., Seite 104024 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Nene, Lindokuhle Cindy [VerfasserIn] |
---|
Links: |
---|
Themen: |
Enhanced photo-mediated, Therapeutic efficacy |
---|
Anmerkungen: |
Date Revised 28.02.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1016/j.pdpdt.2024.104024 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368917983 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM368917983 | ||
003 | DE-627 | ||
005 | 20240229235201.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240229s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.pdpdt.2024.104024 |2 doi | |
028 | 5 | 2 | |a pubmed24n1311.xml |
035 | |a (DE-627)NLM368917983 | ||
035 | |a (NLM)38401819 | ||
035 | |a (PII)S1572-1000(24)00063-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Nene, Lindokuhle Cindy |e verfasserin |4 aut | |
245 | 1 | 0 | |a Phthalocyanine-based probes in alleviating or evading tumour-hypoxia for enhanced photo- and/ sono-mediated therapeutic efficacies |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 28.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved. | ||
520 | |a This review discusses the possible methods for improving therapeutic efficacies of phthalocyanine (Pcs) -based therapeutic probes in photo- and sono-dynamic therapies under hypoxic conditions. Herein, the structural design strategies including varying the central metal, position substituents and the effects of adjuvant used in supplementing the therapeutics activities of Pcs or formation of NPs are discussed for cancer therapies in hypoxic conditions. Different mechanisms induced for cell death influenced by the compositions of the Pcs-probes are discussed. The focus mainly highlights the oxygen (O2) -dependent mechanisms including methods of supplementing tumour microenvironment O2-concentrations to promote PDT or SDT therapies. Alternatively, O2-independent mechanisms mainly used to evade hypoxia by stimulating anticancer processes that don't require O2 to initiate cell death, such as the Fenton reaction or thermal ablation effects | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Enhanced photo-mediated, Therapeutic efficacy | |
650 | 4 | |a Photodynamic Therapy | |
650 | 4 | |a Phthalocyanine-based probes | |
650 | 4 | |a Sono-mediated Therapeutic efficacy | |
650 | 4 | |a Sonodynamic Therapy | |
650 | 4 | |a Tumour-hypoxia | |
700 | 1 | |a Abrahamse, Heidi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Photodiagnosis and photodynamic therapy |d 2004 |g 46(2024) vom: 22. Feb., Seite 104024 |w (DE-627)NLM182218406 |x 1873-1597 |7 nnns |
773 | 1 | 8 | |g volume:46 |g year:2024 |g day:22 |g month:02 |g pages:104024 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pdpdt.2024.104024 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 46 |j 2024 |b 22 |c 02 |h 104024 |